Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

A sequential method of epidermal growth factor receptor mutation detection reduces false negatives: a new case with doublet mutations of L833V and H835L in China.

Zhuang Y, Xu J, Ma H, Zhu W, Guo L, Kang S, Guo F.

Clin Lung Cancer. 2013 May;14(3):295-300. doi: 10.1016/j.cllc.2012.11.003. Epub 2013 Jan 10. No abstract available.

PMID:
23313172
2.

[Epithelial growth factor receptor (EGFR) exon double-sequencing analysis in NSClC].

Lai RS, Xie L, Shen LS, Zhu CL, Qian J.

Zhonghua Zhong Liu Za Zhi. 2006 Aug;28(8):599-602. Chinese.

PMID:
17236554
3.

[The detection methods of EGFR mutations in non-small cell lung cancer].

Zhang X, Liu G, Zhu X, Wang W.

Zhongguo Fei Ai Za Zhi. 2011 Mar;14(3):297-302. doi: 10.3779/j.issn.1009-3419.2011.03.18. Review. Chinese. No abstract available.

4.

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

Mu XL, Li LY, Zhang XT, Wang MZ, Feng RE, Cui QC, Zhou HS, Guo BQ.

Clin Cancer Res. 2005 Jun 15;11(12):4289-94.

5.

Good response to gefitinib in a lung adenocarcinoma harboring a heterozygous complex mutation of L833V and H835L in epidermal growth factor receptor gene.

Yang TY, Tsai CR, Chen KC, Hsu KH, Lee HM, Chang GC.

J Clin Oncol. 2011 Jun 1;29(16):e468-9. doi: 10.1200/JCO.2010.33.5802. Epub 2011 Mar 21. No abstract available.

PMID:
21422421
6.
7.

A blood-based test for epidermal growth factor receptor mutations in lung cancer.

Bell DW, Haber DA.

Clin Cancer Res. 2006 Jul 1;12(13):3875-7. Review. No abstract available.

8.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, Louis DN, Christiani DC, Settleman J, Haber DA.

N Engl J Med. 2004 May 20;350(21):2129-39. Epub 2004 Apr 29.

9.
10.

Dose effect of cigarette smoking on frequency and spectrum of epidermal growth factor receptor gene mutations in Korean patients with non-small cell lung cancer.

Lee YJ, Shim HS, Kang YA, Hong SJ, Kim HK, Kim H, Kim SK, Choi SH, Kim JH, Cho BC.

J Cancer Res Clin Oncol. 2010 Dec;136(12):1937-44. doi: 10.1007/s00432-010-0853-4. Epub 2010 Mar 17.

PMID:
20237940
11.

High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients.

Kimura H, Fujiwara Y, Sone T, Kunitoh H, Tamura T, Kasahara K, Nishio K.

Cancer Sci. 2006 Jul;97(7):642-8.

12.

Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer.

Fukui T, Ohe Y, Tsuta K, Furuta K, Sakamoto H, Takano T, Nokihara H, Yamamoto N, Sekine I, Kunitoh H, Asamura H, Tsuchida T, Kaneko M, Kusumoto M, Yamamoto S, Yoshida T, Tamura T.

Clin Cancer Res. 2008 Aug 1;14(15):4751-7. doi: 10.1158/1078-0432.CCR-07-5207.

13.

Assessing EGFR mutations.

Marchetti A, Felicioni L, Buttitta F.

N Engl J Med. 2006 Feb 2;354(5):526-8; author reply 526-8. No abstract available.

14.

Rapid detection of epidermal growth factor receptor mutations with multiplex PCR and primer extension in lung cancer.

Lin CH, Yeh KT, Chang YS, Hsu NC, Chang JG.

J Biomed Sci. 2010 May 12;17:37. doi: 10.1186/1423-0127-17-37.

15.

Comparison study of the performance of the QIAGEN EGFR RGQ and EGFR pyro assays for mutation analysis in non-small cell lung cancer.

Cushman-Vokoun AM, Crowley AM, Rapp SA, Greiner TC.

Am J Clin Pathol. 2013 Jul;140(1):7-19. doi: 10.1309/AJCPMF26ABEOYCHZ.

PMID:
23765529
16.

High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.

Huang SF, Liu HP, Li LH, Ku YC, Fu YN, Tsai HY, Chen YT, Lin YF, Chang WC, Kuo HP, Wu YC, Chen YR, Tsai SF.

Clin Cancer Res. 2004 Dec 15;10(24):8195-203.

17.

A modified extraction method of circulating free DNA for epidermal growth factor receptor mutation analysis.

Yuan H, Zhu ZZ, Lu Y, Liu F, Zhang W, Huang G, Zhu G, Jiang B.

Yonsei Med J. 2012 Jan;53(1):132-7. doi: 10.3349/ymj.2012.53.1.132.

18.

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.

Miyazawa H, Tanaka T, Nagai Y, Matsuoka M; Huqun., Sutani A, Udagawa K, Zhang J, Hirama T, Murayama Y, Koyama N, Ikebuchi K, Nagata M, Kanazawa M, Nukiwa T, Takenoshita S, Kobayashi K, Hagiwara K.

Cancer Sci. 2008 Mar;99(3):595-600. doi: 10.1111/j.1349-7006.2007.00706.x.

19.

Epidermal growth factor receptor mutations and tyrosine kinase inhibitor therapy in advanced non-small-cell lung cancer.

[No authors listed]

Technol Eval Cent Assess Program Exec Summ. 2007 Nov;22(6):1-3. No abstract available.

PMID:
18080406
20.

Testing epidermal growth factor receptor mutations in patients with non-small-cell lung cancer to choose chemotherapy: the other side of the coin.

Garassino MC, Marsoni S, Floriani I.

J Clin Oncol. 2011 Oct 1;29(28):3835-7; author reply 3837-9. doi: 10.1200/JCO.2011.36.7847. Epub 2011 Aug 29. No abstract available.

PMID:
21876080

Supplemental Content

Support Center